Passage Bio
Sneh Patel has a diverse background in pharmaceuticals, with a focus on analytical method development for gene therapy vectors and bioequivalence studies. Sneh has experience working as a Senior Scientist at Passage Bio and Kashiv BioSciences LLC, where they led projects related to regulatory submissions and method validation. With a Master of Science in Pharmacy Administration and Pharmacy Policy and Regulatory Affairs from Northeastern University, Sneh is well-equipped to excel in the pharmaceutical industry.
This person is not in the org chart
This person is not in any offices
Passage Bio
1 followers
Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).